title: Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy.
abstract: The vacuolar ATPases are ATP-dependent proton pumps whose functions include the acidification of intracellular compartments and the extrusion of protons through the cell cytoplasmic membrane. These pumps play a pivotal role in the regulation of cell pH in normal cells and, to a much greater extent, in tumor cells. In fact, the glucose metabolism in hypoxic conditions by the neoplasms leads to an intercellular pH drift towards acidity. The acid microenvironment is modulated through the over-expression of H+ transporters that are also involved in tumor progression, invasiveness, distant spread and chemoresistance. Several strategies to block/downmodulate the efficiency of these transporters are currently being investigated. Among them, proton pump inhibitors have shown to successfully block the H+ transporters in vitro and in vivo, leading to apoptotic death. Furthermore, their action seems to synergize with conventional chemotherapy protocols, leading to chemosensitization and reversal of chemoresistance. Aim of this article is to critically revise the current knowledge of this cellular machinery and to summarize the therapeutic strategies developed to counter this mechanism.
authors.affiliation: S.A.F.U. Department, Regina Elena Cancer Institute, Rome, Italy.
authors.forename: Enrico P
authors.initials: EP
authors.lastname: Spugnini
authors.forename: Gennaro
authors.initials: G
authors.lastname: Citro
authors.forename: Stefano
authors.initials: S
authors.lastname: Fais
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003593:Cytoplasm / Q000378:metabolism; D018450:Disease Progression; D005786:Gene Expression Regulation; D006801:Humans; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D017494:Proton Pumps / Q000378:metabolism; D025262:Vacuolar Proton-Translocating ATPases / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D054328:Proton Pump Inhibitors; D017494:Proton Pumps; D025262:Vacuolar Proton-Translocating ATPases
references.citation: Science. 2003 Feb 28;299(5611):1400-3
references.pmid: 12610307
references.citation: J Natl Cancer Inst. 2004 Nov 17;96(22):1702-13
references.pmid: 15547183
references.citation: Cancer Res. 2007 Jun 1;67(11):5408-17
references.pmid: 17545622
references.citation: Nucleic Acids Res. 2003 Aug 1;31(15):4523-30
references.pmid: 12888513
references.citation: J Biol Chem. 2000 Jul 21;275(29):22075-81
references.pmid: 10801866
references.citation: Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3497-504
references.pmid: 7909602
references.citation: Cancer Res. 2007 Nov 15;67(22):10627-30
references.pmid: 18006801
references.citation: J Biol Chem. 1994 May 6;269(18):13224-30
references.pmid: 8175752
references.citation: In Vitro Cell Dev Biol Anim. 2008 Jan-Feb;44(1-2):26-30
references.pmid: 18034283
references.citation: Cancer Lett. 2009 Jul 18;280(1):110-9
references.pmid: 19299075
references.citation: Nat Rev Mol Cell Biol. 2007 Nov;8(11):917-29
references.pmid: 17912264
references.citation: Novartis Found Symp. 2001;240:169-81; discussion 181-5
references.pmid: 11727928
references.citation: Biochem J. 1997 Jun 15;324 ( Pt 3):697-712
references.pmid: 9210392
references.citation: Biochem Pharmacol. 1999 May 1;57(9):1037-46
references.pmid: 10796074
references.citation: Nat Rev Cancer. 2005 Oct;5(10):786-95
references.pmid: 16175178
references.citation: J Biol Chem. 2009 Jun 12;284(24):16400-16408
references.pmid: 19366680
references.citation: Biochem Pharmacol. 1999 Feb 1;57(3):309-12
references.pmid: 9890558
references.citation: Nat Rev Cancer. 2004 Nov;4(11):891-9
references.pmid: 15516961
references.citation: J Biol Chem. 2002 Sep 27;277(39):36534-43
references.pmid: 12133827
references.citation: J Biol Chem. 1988 Jun 25;263(18):8796-802
references.pmid: 2897963
references.citation: J Biol Chem. 1992 Oct 5;267(28):19769-72
references.pmid: 1400289
references.citation: J Exp Ther Oncol. 1996 Jan;1(1):49-61
references.pmid: 9414388
references.citation: Cancer Res. 2004 Sep 1;64(17):6160-5
references.pmid: 15342400
references.citation: Cancer Res. 2005 Aug 1;65(15):6843-9
references.pmid: 16061667
references.citation: Biochem Pharmacol. 2003 Oct 1;66(7):1207-18
references.pmid: 14505800
references.citation: Am J Physiol Cell Physiol. 2004 Jun;286(6):C1443-52
references.pmid: 14761893
references.citation: Cancer Res. 2009 Mar 15;69(6):2260-8
references.pmid: 19276390
references.citation: Science. 2002 Mar 29;295(5564):2387-92
references.pmid: 11923519
references.citation: J Clin Invest. 2008 Dec;118(12):3835-7
references.pmid: 19033652
references.citation: Eur Spine J. 2003 Aug;12(4):341-9
references.pmid: 12883962
references.citation: J Biol Chem. 1992 Mar 15;267(8):5700-11
references.pmid: 1544942
references.citation: Am J Physiol. 1993 Oct;265(4 Pt 1):C1015-29
references.pmid: 8238296
references.citation: J Biol Chem. 1999 Oct 8;274(41):28909-15
references.pmid: 10506135
references.citation: Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1128-32
references.pmid: 8302842
references.citation: Arch Biochem Biophys. 2008 Aug 1;476(1):33-42
references.pmid: 18406336
references.citation: J Biol Chem. 2001 Dec 14;276(50):47411-20
references.pmid: 11592965
references.citation: Nat Rev Mol Cell Biol. 2002 Feb;3(2):94-103
references.pmid: 11836511
references.citation: Int J Cancer. 2010 Jul 1;127(1):207-19
references.pmid: 19876915
references.citation: Neoplasia. 2001 May-Jun;3(3):227-35
references.pmid: 11494116
references.citation: Int J Cancer. 2001 Sep;93(6):869-74
references.pmid: 11519050
references.citation: Cancer Res. 2006 Jul 1;66(13):6699-707
references.pmid: 16818644
references.citation: Br J Cancer. 1999 Jun;80(7):1005-11
references.pmid: 10362108
references.citation: J Biol Chem. 1992 Mar 25;267(9):5817-22
references.pmid: 1532573
references.citation: Cancer Res. 2006 Apr 1;66(7):3629-38
references.pmid: 16585188
references.citation: Cancer Res. 1991 Sep 15;51(18):4955-63
references.pmid: 1680024
references.citation: Clin Exp Metastasis. 1996 Mar;14(2):176-86
references.pmid: 8605731
references.citation: Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1147-57
references.pmid: 16679513
references.citation: J Biol Chem. 1999 Jan 15;274(3):1301-5
references.pmid: 9880499
references.citation: Mol Cell Biol. 2005 Jan;25(2):575-89
references.pmid: 15632060
references.citation: Neoplasia. 2003 Nov-Dec;5(6):533-45
references.pmid: 14965446
references.citation: Biochem Pharmacol. 1999 May 1;57(9):1047-58
references.pmid: 10796075
references.citation: Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):599-604
references.pmid: 18423392
references.citation: Br J Cancer. 2003 Sep 1;89(5):877-85
references.pmid: 12942121
references.citation: Mol Pharmacol. 1988 Aug;34(2):180-5
references.pmid: 2901030
references.citation: Biochem Pharmacol. 2003 Oct 1;66(7):1219-29
references.pmid: 14505801
references.citation: J Biol Chem. 2006 Aug 11;281(32):22752-60
references.pmid: 16774922
references.citation: Nat Rev Cancer. 2010 Feb;10(2):147-56
references.pmid: 20075923
references.citation: Drug Discov Today. 2009 Jul;14(13-14):647-60
references.pmid: 19443264
references.citation: Methods Mol Med. 2006;124:347-64
references.pmid: 16506429